IPO Plus

NSE · JHS · FMCG

JHS Svendgaard Laboratories Ltd.

7.47
₹65 Cr market cap
P/E
EPS
₹-0.42
Book value
₹19.98
ROE
-1.1%
ROCE
0%
Debt / equity
0.09

Revenue & net profit by period

Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.

023.7247.4471.1694.87Sep 24Dec 24Mar 25Mar 25Jun 25Sep 25Dec 25Mar 26
Revenue (₹ Cr) Net profit (₹ Cr)

Latest period: revenue ₹33 Cr with net profit ₹-4 Cr — a -10.92% net margin, versus 3.39% the period before.

Shareholding

As of 2026-06-30

33.85%
promoter holding
  • Promoter33.85%
  • Public63.01%
  • FII3.14%

25,150 shareholders on record

Promoter holding trend

Each disclosed period, oldest to newest

34.56%33.85%Dec 24Jun 26

52-week position

Where the current price sits in its yearly band

6.267.4713.9

The band spans 2.22× from low to high.

Risk flags

Derived from disclosed data

No flags raised by the data.

Peer comparison

Personal Care - Indian · ranked #10 of 14 by market cap · medians across 12 industry peers

P/E
vs 193.24 peer med
P/B
0.37vs 6.42 peer med
ROE %
-1.1vs 14.22 peer med
Margin %
-1.89vs 9.29 peer med
CompanyMkt capP/EP/BROEMargin
Godrej Consumer Products Ltd.₹1,10,152 Cr243.558.7114.71%12.16%
Lenskart Solutions Ltd.₹97,308 Cr209.6111.135.65%5.6%
Dabur India Ltd.₹76,936 Cr208.516.7416.59%14.36%
Cupid Limited₹31,434 Cr865.8169.7324.01%30.26%
Emami Limited₹17,803 Cr124.346.0926.51%20.51%
Jyothy Labs Limited₹7,572 Cr112.064.7718.07%13.01%
Bajaj Consumer Care Ltd.₹7,008 Cr112.959.2825.19%16.49%
Radix Industries (India) Ltd.₹225 Cr779.5613.72%6.41%
Thrive Future Habitats Limited₹93 Cr1.77-1.94%-85.25%
JHS Svendgaard Laboratories Ltd.(this company)₹65 Cr0.37-1.1%-1.89%

AI analysis

AI-generated · google/gemini-2.5-flash

JHS Svendgaard Laboratories Ltd. is listed on the Indian markets with a market capitalization of Rs 65 Cr. The company reported revenue of Rs 94.87 Cr and an EPS of -Rs 2.31. Its 52-week trading range has been between Rs 6.26 and Rs 13.9.

Positives

  • +The company has a low debt-to-equity ratio of 0.03.
  • +Promoter holding of 33.85% is not pledged.

Negatives

  • The company reported a negative EPS of -Rs 2.31.
  • Return on Capital Employed (ROCE) is negative at -0.75%, indicating inefficient use of capital.
  • Net profit for the year ending March 2025 was negative at -Rs 19.74 Cr.
  • The promoter holding decreased from an unspecified value to 33.85% between March 2017 and June 2026 (exact former value not provided, but history shows changes).

Financial Performance

For the financial year ending March 2025, JHS Svendgaard Laboratories Ltd. reported a revenue of Rs 94.87 Cr. The company recorded a net loss of Rs 19.74 Cr in the same period, with an EPS of -Rs 2.37. Quarterly revenue for March 2026 was Rs 32.7 Cr, with a net loss of Rs 3.57 Cr.

Profitability & Returns

The company's Return on Capital Employed (ROCE) stands at -0.75%. The Enterprise Per Share (EPS) for the latest reported period is -Rs 2.31, indicating a loss per share. The company has not reported a positive Return on Equity (ROE).

Balance Sheet

JHS Svendgaard Laboratories Ltd. has a Book Value per share of Rs 19.89. The debt-to-equity ratio is 0.03, suggesting a low reliance on debt for financing. Further details regarding other assets and liabilities are not available in the provided data.

Ownership & Pledges

As of June 30, 2026, promoter holding in JHS Svendgaard Laboratories Ltd. was 33.85%. Public shareholding was 63.01%. Foreign Institutional Investors (FIIs) held 3.14% of the shares. There were no promoter pledges reported.

Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.

How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.

Back to JHS Svendgaard Laboratories Ltd.share price & fundamentals

Telegram App